Key Takeaways:
- UK-based Ruka secured funding to scale its lab-grown hair fiber technology, Synths 2.
- Ruka fibers essentially eradicate the need for human hair on the extensions market.
- Freedom Trail Capital and Henkel Ventures co-led the funding round.
Ruka, the biotech beauty startup, has closed a $4.5 million funding round co-led by Freedom Trail Capital and Henkel Ventures.
WHO: Ruka was founded in 2020 by Tendai Moyo and Ugo Agbai, positioning itself at the intersection of materials science and the textured hair market. Ruka, a DTC hair extension brand designed specifically for Afro-Caribbean hair textures aiming to provide natural-looking options, has built a following through education-led community building and a broad portfolio spanning human hair extensions, wigs, styling products, hair perfumes, and tools. Its latest innovation, Synths 2, is a patent-pending collagen-based fiber designed to mimic the look and feel of human hair while avoiding the plastic fibers and sourcing concerns associated with traditional extensions.
WHY: The investment will fuel the growth of Ruka's retail footprint, bolster production, and support its 2026 expansion into the US.
IN THEIR OWN WORDS: Tendai Moyo told BoF that securing investment proved more complex than a typical beauty fundraising process: “Beauty investors understand consumer and retail distribution, and biotech investors understand material science. It’s very difficult to find investors who sit at that intersection,” she said.
“Ruka Hair exemplifies what we look for: founders solving a real problem with genuine commitment, building through community rather than hype,” said Samyr Laine, co-founder and Managing Partner...
